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Abstract 
 
This study includes the Synthesis of Azoles Based p-nitro Benzoic Acid Derivative. The compounds were prepared 
by reaction of p-nitro Benzoic Acid with thiosemicarbazide in the presence of Phosphorus oxychloride to yield 1, 3, 
4-thiadiazole nucleus. Further this thiadiazole was treated with different aromatic aldehydes in presence of methanol 
to yield corresponding Schiff’s bases. All the Schiff’s bases thus obtained were reacted with Thioglycolic acid to 
yield the title compounds. Synthesized derivatives were characterized by IR, H
1
NMR and screened for their 
antibacterial (S. aureus, B. subtilis, E. coli, and P. aerugiosa) and antifungal activity (A. Niger and C. albicans). 
 
Key Words: Azole derivative, p-nitro Benzoic Acid derivative, antimicrobial activity. 
Introduction 
Medicine is defined as a system of scientific 
knowledge and practical activities aimed at preserving 
and improving the health of society including 
prevention and treatment of human disease. This would 
serve as the basis for ensuring good health for a 
community Tradition Antimicrobial resistance is 
becoming a serious threat to global public health. As 
per WHO around 45-50 thousand people face the drug 
resistance in tuberculosis disease.[1] As per  all Indian 
medicine-a conglomerate of Ayurveda, Sidha and 
Unani has a long history The 4-thiazolidinones that do 
not contain aryl or higher alkyl substituents are 
somewhat soluble in water or thiazolidinone that do not 
contain aryl or higher alkyl substituents are somewhat 
less soluble in water[2] Thiadiazole is a heterocyclic 
compound featuring both a nitrogen and sulphur atom 
as a part of the aromatic five membered rings.  
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It acts as Hydrogen bonding domain and two electron 
donor moiety along with ability of Bio-isosteric 
replacement of thiazole moiety. Bioisosteres are atoms 
or group of molecules that fit the broadest definition 
for isosteres. [3-5]. Thiazole is resistant to oxidizing 
agents; even hot nitric acid has little effect. It is either 
unaffected by reducing agents or at most some ring 
opening occurs it is therefore not possible to make 
dihydrothiazoles or thiazolidines by catalytical 
dehydrogenation but they must need to be prepared by 
means of condensation reactions. Thiazole is of great 
biological importance as it is used as an intermediate to 
manufacture synthetic drugs, fungicides and dyes. A 
thiazole ring is found in the essential vitamin B1 [7].  
The literature survey showed that the Thiadiazole 
moiety exhibit antimicrobial, anti cancer, anti 
inflammatory, antioxidant Anti Fungal, anti depressant, 
anti-Anthelmintic activity. [8-13]. Five membered 
heterocyclic compounds show various types of 
biological activities. Among these, Thiadiazole are 
associated with diverse pharmacological actions 
probably by virtue of –N=C-S- grouping. Thiadiazole 
moiety acts as a “hydrogen binding domain” and “two-
electron donor system”. Thiadiazole acts as a 
bioisosteric replacement of thiazole moiety. So, it acts 
as third and fourth generation cephalosporin and hence 
can be used in antibiotic preparations [19].The 
numbering of monocyclic azole systems begins with 
the heteroatom that is in the highest group in the 
periodic table and with the element of lowest atomic 
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weight in that group. Hence, the numbering of 1, 3, 4-
thiadiazole is done in the following manner. This 
designated that one sulphur group is present in the ring 
[20]. 
 
Materials and Methods 
The chemical used for experimental were of synthetic 
grade and procured from Nice Laboratory, Loba 
Chemie Private Limited, CDH New Delhi and 
Research Lab Fine Chem industries Mumbai. The 
melting points of the synthesized compounds were 
determined in open glass capillaries and are 
uncorrected. IR spectra were recorded on FTIR 
Spectrometer. H
1
NMR spectra were recorded on were 
recorded in CDCl3/DMSO solution on a Bruker 
Avance II 400 MHz NMR spectrometer taking 
Tetramethylsilane (TMS) as internal standard. Progress 
of reaction was monitored by TLC using solvent 
Hexane: Ethyl acetate (40%) & Methanol: Chloroform 
(1%). 
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Synthetic procedure 
Synthesis of 5-(4-nitrophenyl)-1, 3, 4-thiadiazol-2-
amine 
A mixture of equimolar quantity of p-Nitro Benzoic 
Acid (50mmol) and thiosemicarbazide (50 mmol) were 
refluxed in 20 ml POCl3 solution for 2 h at 75
0
C. After 
cooling down to room temperature, cold water was 
added. The mixture was again refluxed for 4 h. The 
content was cooled down at room temperature and 
made alkaline at pH 8.0 by addition of 50 % NaOH 
solution. The solid 5-(4-nitrophenyl)-1, 3, 4-thiadiazol-
2-amine (compound 3) so obtained was filtered and 
recrystallized using ethanol. (Bhatia et al) 
Synthesis of Schiff bases 
In this step compound 3 i.e. 5-(4-nitrophenyl)-1, 3, 4-
thiadiazol-2-amine was refluxed with different 
substituted aromatic aldehydes (0.025M) [a-k] using 
methanol (50 mL) as solvent in presence of small 
amount of glacial acetic acid for 2 hrs. The mixture 
was cooled and poured in ice water. The content was 
put undisturbed for 24h. The solid thus obtained was 
separated by filtration and recrystallized from 
 
Asian Pac. J. Health Sci., 2018; 5(4):54-60                                                e-ISSN: 2349-0659, p-ISSN: 2350-0964 
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Sharma et al                       ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2018;5(4):54-60                                    56 
www.apjhs.com       
 
Methanol to give the Corresponding Schiff bases (a-k). 
[21-23] and Kumar et al 2018] 
Synthesis of Thiazolidinone 
A mixture of Synthesized Schiff base (0.02M) (a-k) 
and Thioglycolic acid (0.02M) in 50ml DMF, 
containing a pinch of anhydrous ZnCl2 were refluxed 
for about 6 hrs. The reaction mixture was cooled and 
poured on to crushed ice. The solid thus obtained was 
filtered, washed with water and the product 
thaizolidinone (6a-k) was recrystallized from ethanol. 
[Sharma et al 2010]. 
Characterization of synthesized compounds: 
Compound 1 
2-(4-Chloro-phenyl)-3-(5-(4-nitro-phenyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
) 3013.18 (C-H str, aromatic), 1672.7 
(C=O str.), 1639.1 (C=N str.), 1297 (C-N), 831.42(C-
Cl). 
1H NMR (DMSO) (δ-ppm):  7.1-8.15 (8H, Ar H); 
5.6 (1H, N-CH); 3.5 (1H, CH-S) 
Compound 2 
2-(2-Fluorophenyl)-3-(5-(4-nitro-phenyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one  
IR (KBr) (cm
-1
) 3019.15 (C-H str, aromatic), 1674.5 
(C=O str.), 1643.9 (C=N str.), 1292.1 (C-N), 830.47(C-
F). 
1H NMR (DMSO) (δ-ppm):  7.0-8.18 (8H, Ar H); 
5.58 (1H, N-CH); 3.68 (1H, CH-S) 
Compound 3 
2-(2-Nitro-phenyl)-3-(5-(4-nitro-phenyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one  
IR (KBr) (cm
-1
) 3015.6 (C-H str, aromatic), 1667.6 
(C=O str.), 1640.1(C=N str.), 1285.7 (C-N),  
1H NMR (DMSO) (δ-ppm):  7.27-8.24 (8H, Ar H); 
5.71 (1H, N-CH); 3.73 (1H, CH-S) 
Compound 4 
2-(3-Hydroxy-phenyl)-3-(5-(4-nitro-phenyl)-[1, 3, 
4]-thiadiazol-2-yl)-thiazolidin-4-one  
IR (KBr) (cm
-1
): 3381.10 (O-H str.), 3004.3 (C-H str, 
aromatic), 1667.1 (C=O str.), 1641.5(C=N str.), 1293 
(C-N),  
1
H NMR (DMSO) (δ-ppm):  6.90-7.90 (8H, Ar -H); 5.9 
(1H, N-CH); 4.94 (Ar-OH), 3.78 (1H, CH-S) 
Compound 5 
2-(4-Hydroxyphenyl)-3-(5-(4-nitro-phenyl)-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one  
IR (KBr) (cm
-1
): 3385.6 (O-H str.), 3007.1(C-H str, 
aromatic), 1673.4 (C=O str.), 1642.9(C=N str.), 1291 
(C-N),  
1H NMR (DMSO) (δ-ppm):  6.90-8.10 (8H, Ar -H); 
5.84 (1H, N-CH); 4.90 (Ar-OH), 3.68 (1H, CH-S) 
 
 
Compound 6 
2-(2-Methoxy-phenyl)-3-(5-(4-nitro-phenyl)-[1, 3, 
4]-thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
) 3010.4 (C-H str, aromatic), 1669.5 
(C=O str.), 1642.4(C=N str.), 1288.3 (C-N), 1232.5 
(OCH3) 
1H NMR (DMSO) (δ-ppm):  6.90-7.95 (8H, Ar -H); 
5.85 (1H, N-CH); 3.97 (-OCH3), 3.56 (1H, CH-S) 
Compound 7 
2-(4-Methoxy-phenyl)-3-(5-(4-nitro-phenyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
) 3010.5(C-H str, aromatic), 1666.7 
(C=O str.), 1639.1(C=N str.), 1285.5 (C-N), 1233.2 
(OCH3) 
1H NMR (DMSO) (δ-ppm):  6.85-8.10 (8H, m, Ar -H); 
5.82 (1H, N-CH); 3.82 (1H, s, -OCH3), 3.50 (1H, s, 
CH-S) 
Compound 8 
3-[5-(4-Nitro-phenyl) - [1, 3, 4]-thiadiazol-2yl)-2-
phenyl-thiazolidin-4-one 
IR (KBr) (cm
-1
) 3006.9(C-H str, aromatic), 1665.0 
(C=O str.), 1641.7(C=N str.), 1286.2 (C-N), 
1H NMR (DMSO) (δ-ppm):  7.05-8.18 (9H, m, Ar -H); 
5.85 (1H, s, N-CH), 3.51 (1H, s, CH-S) 
Compound 9 
2-(2, 4-Dichlorophenyl)-3-(5-(4-nitro-phenyl-[1, 3, 
4]-thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
) 3004.0(C-H str, aromatic), 1658.2 
(C=O str.), 1643.5(C=N str.), 1284.8 (C-N), 
1H NMR (DMSO) (δ-ppm):  6.95-7.98(7H, m, Ar -H); 
5.88 (1H, s, N-CH), 3.43 (1H, s, CH-S) 
Compound 10 
2-(2-Nitrophenyl)-3-(5-(4-nitro-phenyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
) 2996.0(C-H str, aromatic), 1663.1 
(C=O str.), 1645.9(C=N str.), 1278.8 (C-N), 
1H NMR (DMSO) (δ-ppm):  7.25-8.05 (8H, m, Ar -H); 
5.90 (1H, s, N-CH), 3.45 (1H, s, CH-S) 
Compound 11 
2-(2-Bromo-phenyl)-3-(5-94-nitro-phenyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
) 2998.7(C-H str, aromatic), 1664.2 
(C=O str.), 1644.9(C=N str.), 1279.3(C-N), 
1
H NMR (DMSO) (δ-ppm):  7.05-8.10 (8H,m, Ar -H); 
5.85 (1H,s, N-CH), 3.49 (1H, s, CH-S) 
Biological Activity 
Keeping in view the activity profile of Thiazolidinone 
and Thiadiazole itself, it was thought sensible to carry 
out biological screening of all the newly synthesized 
compounds. Therefore all the synthesized compounds 
were subjected to Antimicrobial evaluation. 
 
 
Asian Pac. J. Health Sci., 2018; 5(4):54-60                                                e-ISSN: 2349-0659, p-ISSN: 2350-0964 
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Sharma et al                       ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2018;5(4):54-60                                    57 
www.apjhs.com       
 
Antibacterial activity 
The antibacterial activities of compounds were 
determined in vitro against Gram-positive 
(Staphylococcus aureus, Bacillus subtilis) and Gram-
negative (Escherichia coli, P. aeuroginosa) bacteria by 
tube dilution method. Double strength nutrient broth- 
(I.P.) media and sabourand’s glucose broth media- 
(I.P.) were used for bacteria and fungi respectively. 
The samples were incubated at 37 °C for 24 h 
(bacteria), at 25 °C for 7 d (A. Niger) and at 37 °C for 
48 h (C. albicans) and the results were recorded in 
terms of minimum inhibitory concentration (MIC). 
Ciprofloxacin and fluconazole were taken as standard 
drugs for antibacterial and antifungal activity, 
respectively.  
Determination of MIC 
MIC of compounds was determined by two fold serial 
dilution technique. Dilution of test compound and 
standard drugs were prepared in test medium to give a 
concentration of 50, 25, 12.5, 6.25, 3.125 and 1.56 
µg/ml from stock solution (100µg/ml). All the samples 
were inoculated with 0.1ml suspension of bacteria in 
saline and incubated at required temperature. MIC was 
determined by lowest concentration of sample that 
prevents the development of turbidity. [18] The 
observed MIC is presented in Table 1. 
Table-1: Minimum Inhibitory Concentration (MIC) 
Comp- 
ounds 
 
Minimum Inhibitory Concentration (MIC) 
Bacterial strains Fungal strains 
Gram Positive Gram Negative 
S. aureus B. subtilis P. aeruginosa E.coli C. albicans A. niger 
1 1.610 1.610 1.610 1.610 1.610 1.610 
2 0.842 0.842 0.842 0.842 0.842 0.842 
3 1.570 1.570 0.785 0.785 1.570 1.570 
4 1.689 1.689 1.689 1.689 1.689 1.689 
5 1.689 1.689 1.689 1.689 1.689 1.689 
6 1.74 1.74 1.74 1.74 0.870 0.870 
7 1.74 1.74 1.74 1.74 0.870 0.870 
8 1.77 1.77 1.77 1.77 1.77 1.77 
9 0.740 0.740 0.740 0.740 1.48 1.48 
10 1.570 1.570 0.785 0.785 1.570 1.570 
11 0.723 0.723 0.723 0.723 0.723 0.723 
Std.  0.471 0.471 0.471 0.471 0.510 0.510 
Standard: ciprofloxacin (antibacterial) and fluconazole (antifungal). 
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Result and discussion 
The Title compounds were synthesized as per the 
procedure mentioned under heading Synthetic 
procedure.  The synthesized compounds were 
recrystallized and purity of the compounds was 
ascertained by using appropriate solvent systems (ethyl 
acetate: benzene: water). The compounds were 
characterized by their IR and NMR spectroscopic data. 
The result of IR and HNMR data are in good 
agreement with their theoretical values. The 
Physiochemical data of Synthesized Thiazolidinone 
derivatives is presented in table 2. Compounds 2, 3, 6, 
7,9,10, 11 showed the significant antimicrobial activity 
against different strains of microbes. 
 
Table 2: Characterization (Physiochemical) data of compounds 
 
 
Compound no Ar- Molecular formula  Molecular 
weight 
Melting 
point 
% yield 
1 
Cl
 
C17H11ClN4O3S2 418.88 206-208 71 
2 
F  
C17H11FN4O3S2 402.42 200-203 74 
3 
NO2  
C17H11N5O5S2 429.43 180-182 76 
4 
HO  
C17H12N4O4S2 400.43 185-187 76 
5 
HO
 
C17H12N4O4S2 400.43 184-187 75 
6 OCH3
 
C18H14N4O4S2 414.46 174-176 74 
7 
H3CO  
C18H14N4O4S2 414.46 172-174 76 
8 
 
C17H12N4O3S2 384.43 180-183 72 
9 
Cl
Cl  
C17H19Cl2N4 O3S2 453.32 190-193 67 
10 
O2N  
C17H11N5O5S2 429.43 190-192 70 
11 
Br  
C17H11BrN4 O3S2 463.33 194-197 64 
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Conclusion 
In the present work two azole containing moiety i.e. 
Thiadiazole and Thiazolidinone were clubbed to obtain 
their synergistic effect and evaluated for their 
antimicrobial effect. The experimental data of the 
present research work reveals that synthesized azole 
derivatives of demonstrate significant Antibacterial and 
Antifungal Activity. Compound 2, 3, 6, 7,9,10, 11 
showed significant antimicrobial activity (table 1) 
Further, it has been observed that Thiadiazole which 
are substituted by halogen (-Cl, -Br, -F) with electron 
withdrawing property exhibits more Antimicrobial 
activity than the other.  
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